Videoconference Intervention for Distance Caregivers of Patients With Cancer: A Randomized Controlled Trial
- Resource Type
- Authors
- Smitha S. Krishnamurthi; Amy R. Lipson; Kim Day; Sara L. Douglas; Polly Mazanec; Eric Blackstone; David L. Bajor; Joel N. Saltzman
- Source
- JCO Oncol Pract
- Subject
- Adult
Male
2019-20 coronavirus outbreak
medicine.medical_specialty
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Cost-Benefit Analysis
ORIGINAL CONTRIBUTIONS
law.invention
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
Quality of life
law
Intervention (counseling)
Neoplasms
Surveys and Questionnaires
Medicine
Humans
030212 general & internal medicine
Oncologists
Oncology (nursing)
business.industry
SARS-CoV-2
Health Policy
Cancer
COVID-19
Middle Aged
medicine.disease
Anxiety Disorders
Distress
Oncology
Caregivers
030220 oncology & carcinogenesis
Physical therapy
Quality of Life
Videoconferencing
Anxiety
Female
medicine.symptom
business
- Language
- ISSN
- 2688-1535
PURPOSE: Approximately 20% of caregivers (CGs) live > 1 hour away from the patient and are considered distance caregivers (DCGs) who often report higher distress and anxiety than local CGs. The purpose of this study was to test the effectiveness of an intervention aimed at reducing anxiety and distress in DCGs of patients with cancer. METHODS: This randomized controlled trial enrolled DCGs of patients with all cancer types who were being seen monthly by oncologists in outpatient clinics. There were three arms of the intervention delivered over a 4-month period: arm 1 (a) received 4 monthly videoconference-tailored coaching sessions with an advanced practice nurse or social worker focused on information and support, (b) participated in patient’s appointments with the oncologist via videoconference over the 4-month study period, and (c) had access to a website designed for DCGs. Arm 2 did not receive the coaching sessions but received the other two components, and arm 3 received access to the DCG website only. RESULTS: There were 302 DCGs who provided pre- and postintervention data. There were significant anxiety by group ( P = .028 and r = 0.16) and distress by group interactions ( P = .014 and r = 0.17). Arm 1 had the greatest percentage of DCGs who demonstrated improvement in anxiety (18.6%) and distress (25.2%). CONCLUSION: Coaching and use of videoconference technology (to join the DCG into the patient-oncologist office visit) were effective in reducing both anxiety and distress for DCGs. These components could be considered for local CGs who—with COVID-19—are unable to accompany the patient to oncologist visits.